Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,508,969,981
New position
Shares Held
17,792,161
first reported quarter
Ownership
1.15%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 94.50939096155886.ToString("F0")%
Shared 0.7310354262194457.ToString("F0")%
None 4.759573612221697.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $19,026,917,368 across 16 Drug Manufacturers - General names. AZN ranks #2 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,471,778 | $4,113,007,243 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
17,792,161 | $3,508,969,981 | |
| 3 | ABBV |
AbbVie Inc.
|
14,552,069 | $3,164,929,479 | |
| 4 | JNJ |
Johnson & Johnson
|
10,474,706 | $2,560,437,127 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,267,205 | $1,956,782,081 | |
| 6 | PFE |
Pfizer Inc
|
28,341,834 | $795,838,692 | |
| 7 | NVO |
Novo Nordisk A S
|
16,083,479 | $591,067,849 | |
| 8 | AMGN |
Amgen Inc
|
1,500,535 | $527,963,233 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,508,969,981 | 17,792,161 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||